Simply Good Foods to Report First Quarter Fiscal Year 2026 Financial Results on Thursday, January 8, 2026 GlobeNewswire December 17, 2025 DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results […]
OTC Markets Group Welcomes Cabral Gold Inc. to OTCQX GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cabral Gold Inc. (TSX-V: CBR; OTCQX: CBGZF), a junior resource company, has qualified to trade
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 17, 2025 BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that Dipal Doshi, Chief Executive Officer, will deliver a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026. The Company's presentation and fireside chat will begin at 9 a.m. PT / 12 p.m. ET. https://mma.prnewswire.com/media/1983916/Viatris_OUS_Logo.jpg A live webcast of the event can
According to MarketsandMarkets™, the non-anticoagulant rodenticides marketis projected to grow from USD 1.11 billion in 2025 and to reach USD 1.43 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse150 market data Tables and75 Figures spread through 210 Pages and in-depth TOC on 'Non-Anticoagulant Rodenticides Market
(NYSE:ABM), Fourth quarter revenue was a record $2.3 billion, an increase of 5.4% over the prior year, with organic growth of 4.8% contributing meaningfully to overall performance Net income for the quarter totaled $34.8 million, or $0.56 per diluted share, improving from a net loss of $(11.7) million, or $(0.19) per share, a year ago
ABM Reports Fourth Quarter and Full Fiscal 2025 Results and Provides Fiscal 2026 Outlook Excluding prior year self-insurance adjustments, organic growth, adjusted EPS and adjusted EBITDA exceed management expectations GlobeNewswire December 17, 2025 Fourth quarter revenue was a record $2.3 billion, an increase of 5.4% over the prior year, with organic growth of 4.8% contributing
(NYSE:ABM), NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a major provider of integrated facility, infrastructure, and technical solutions, today announced a definitive agreement to acquire WGNSTAR, a leading provider of managed workforce solutions and equipment support services for the semiconductor and high-technology industries, in a cash transaction valued at approximately $275
ABM Expands Semiconductor and Technical Services Platform with Agreement to Acquire WGNSTAR Strategic acquisition will strengthen ABM's position in fast-growing semiconductor and technology manufacturing markets GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a major provider of integrated facility, infrastructure, and technical solutions, today announced a definitive agreement
CHICAGO and MILWAUKEE and NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced distributions for the YieldMax(R) Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: December 18th,2025Payment Date: December 19th, 2025 ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5 ABNY YieldMax(R)